About CathWorks
CathWorks is a Healthcare company based in Kfar Saba (Israel) founded in 2013 by Ifat Lavi and Guy Lavi, and was acquired by Medtronic in April 2026. Angiogram-based physiology measurement technology is developed without wires or stimuli. CathWorks has raised $150.8 million across 4 funding rounds from investors including Medtronic, GF Securities and Deerfield. CathWorks offers products and services including FFRangio System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Screening Devices. Its legal entity is CathWorks Inc.
Company details
CathWorks was founded in 2013 in Kfar Saba, Israel, operating in the medical technology sector with a focus on cardiology. FFRAngio technology is being developed to enable physiology measurements from angiograms, relying on visual data processing and multi-layered algorithms. Coronary angiography utilization is improved in cath labs to support measurement-based decisions, bypassing requirements for pressure wires or hyperemic agents.
Products & Services of CathWorks
CathWorks offers a comprehensive portfolio of products and services, including FFRangio System.
AI system for assessing fractional flow reserve from angiograms
Apps and channels of CathWorks
its YouTube channel CathWorks has 364 subscribers and 30 videos.
Videos from CathWorks
The most watched videos on CathWorks's YouTube channel, CathWorks (364 subscribers). Click a video to play it here.
More on CathWorks.
Funding Insights of CathWorks
CathWorks has successfully raised a total of $150.8M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $75 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150.8M
- Total Rounds 4
- Last Round Series E — $75M
- First Round $15.8M
(Oct 2017)
- Investors Count 9
All 4 funding rounds of CathWorks with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $75M | Series E | – | Medtronic | – |
| Jan 2021 | $30M | Series D | – | – | – |
| Feb 2019 | $30M | Series C | – | Deerfield | – |
| Oct 2017 | $15.8M | Series B | – | Quark Venture, Triventures |
9 investors in total: 9 institutional.
Investors in CathWorks
CathWorks has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, GF Securities and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Tech & Life Sciences focused early stage VC firm investing in North America | quarkventure.com | Vancouver, Canada | ||
Planven is recognized as a leading growth equity firm. | planven.com | Zurich, Switzerland | ||
Pontifax Venture Capital is focused on life sciences investments. | pontifax.com | Herzeliya, Israel | ||
Corundum Open Innovation is engaged in venture capital investments. | 2015 | corundumoi.com | Herzelia Pituah, Israel | |
Venture capital firm investing in early stage healthcare startups | triventures.vc | Herzliya, Israel | ||
Healthtech startups are funded by BioStar Capital's venture capital efforts. | biostarcapital.com | Charlevoix, United States | ||
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States | |
Provider of investment & asset management and financial services | 1991 | gf.com.cn | Guangzhou, China |
Investor details for CathWorks
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CathWorks
40 people are tracked at CathWorks (10 in leadership, 5 in board & advisors, 25 in team).
| Name | Role | Group |
|---|---|---|
Ifat Lavi | Founder & CTO | Leadership |
Guy Lavi | Co-Founder & President | Leadership |
Dalit Cohen-Shipperman | VP Global HR **we Are Hiring** | Leadership |
Mica Mor BenDavid | VP Global Operations & Finance | Leadership |
Mike Feher | Chief Financial Officer | Leadership |
Alex Froimovich | Sr. Director Of Clinical Affairs | Leadership |
Ramin Mousavi | President & Chief Executive Officer | Leadership |
Asaf Jazcilevich | Vp, Global R&d, Israel Site Leader | Leadership |
Moshe Ran | Director Of Software Development | Leadership |
Natalie Sickler | Chief of Staff | Leadership |
Scott Ward | Chairman | Board & advisors |
Ran Kornowski | Advisor | Board & advisors |
Andrew Elbardissi | Director | Board & advisors |
David Neustaedter | Director | Board & advisors |
Matt Gaylord | Director | Board & advisors |
Amirah Aryan | Senior Physician Trainer | Team |
Shay Divald | Algorithm Developer | Team |
Shira Kleinfeld | Associate Biomedical Engineer | Team |
Tal Meisler | SQA Engineer | Team |
Hector Gutierrez Guerra | Sr. IT Operations Analyst | Team |
20 more people are available in the full profile.
Complete people profiles for CathWorks
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CathWorks
4 dated milestones of CathWorks across 13 years, from founding to its latest funding, stage changes and deals.
- Founded CathWorks is founded.
- Funding First funding round of $15.8M.
- Funding Latest funding round, Series E, of $75.0M.
- Exit Acquired by Medtronic.
Web traffic of CathWorks
The website of CathWorks (cath.works) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 21.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cathworks
Complete news archive for CathWorks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CathWorks
CathWorks was founded in 2013 and raised its 1st funding round 4 years after it was founded.
CathWorks is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.
CathWorks is a funded company, having raised a total of $150.8M across 4 funding rounds to date. The company's 1st funding round was a Series B of $15.8M, raised on Oct 2017.
CathWorks was founded in 2013 in Kfar Saba, Israel, operating in the medical technology sector with a focus on cardiology. FFRAngio technology is being developed to enable physiology measurements from angiograms, relying on visual data processing and multi-layered algorithms. Coronary angiography utilization is improved in cath labs to support measurement-based decisions, bypassing requirements for pressure wires or hyperemic agents.
CathWorks offers FFRangio System.
CathWorks has 9 investors. Key investors include Medtronic, GF Securities, Deerfield, Quark Venture, and Planven.
CathWorks operates through Cathworks Inc..
Yes. CathWorks was acquired by Medtronic in April 2026.

